Jerry Heindel

Dr. Jerry Heindel

Healthy Environment and Endocrine Disruptor Strategies, Bolinas, CA 94924, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2022 in Biochemical Pharmacology
Verified
Journal Article
Closed access
RLRobert H. Lustig
Robert H. Lustig
DCDavid Collier
David Collier
CKChristopher Kassotis
Christopher Kassotis
TRTroy A. Roepke
Troy A. Roepke
MKMin Ji Kim
Min Ji Kim
Jerry HeindelJerry Heindel
Jerry Heindel

5 April 2022 in Biochemical Pharmacology
Verified
Journal Article
Closed access
Jerry HeindelJerry Heindel
Jerry Heindel
SHSarah Howard
Sarah Howard
KAKeren Agay-Shay
Keren Agay-Shay
JAJuan P. Arrebola
Juan P. Arrebola
KAKarine Audouze
Karine Audouze
BBBruce Blumberg
Bruce Blumberg

11 January 2024 in International Journal of Obesity
Verified
Journal Article
Open access
PDF file
Jerry HeindelJerry Heindel
Jerry Heindel
RLRobert H. Lustig
Robert H. Lustig
SHSarah Howard
Sarah Howard
BCBarbara E. Corkey
Barbara E. Corkey
Despite varied treatment, mitigation, and prevention efforts, the global prevalence and severity of obesity continue to worsen. Here we propose a combined model of obesity, a unifying paradigm that links four general models: the energy balance model (EBM), based on calories as the driver of weight gain; the carbohydrate-insulin model (CIM), based on insulin as a driver of energy storage; the oxidation-reduction model (REDOX), based on reactive oxygen species (ROS) as a driver of altered metabolic signaling; and the obesogens model (OBS), which proposes that environmental chemicals interfere with hormonal signaling leading to adiposity. We propose a combined OBS/REDOX model in which environmental chemicals (in air, food, food packaging, and household products) generate false autocrine and endocrine metabolic signals, including ROS, that subvert standard regulatory energy mechanisms, increase basal and stimulated insulin secretion, disrupt energy efficiency, and influence appetite and energy expenditure leading to weight gain. This combined model incorporates the data supporting the EBM and CIM models, thus creating one integrated model that covers significant aspects of all the mechanisms potentially contributing to the obesity pandemic. Importantly, the OBS/REDOX model provides a rationale and approach for future preventative efforts based on environmental chemical exposure reduction.

23 August 2018 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Open access
PDF file
Jerry HeindelJerry Heindel
Jerry Heindel
At the Prenatal Programming and Toxicity (PPTox) Conference I in 2008, I presented an overview of the developmental origins of health and disease field focusing on environmental chemical exposures and disease outcomes. At that time, I noted that the field was getting off the ground with a focus on developmental exposure to a small number of endocrine disrupting chemicals (EDCs) and disease outcomes across the lifespan in animal models. In this update, I note that the DOHaD field has changed significantly over the last decade. There are new windows of susceptibility including preconception, prepuberty, a focus on the mother and not just the offspring, and a significant focus on the new field of epigenetic transgenerational inheritance. New disease focus areas have sprung up including obesity, type 2 diabetes and fatty liver disease, all with a connection to developmental exposures to EDCs. There is also a focus on the study of new EDCs, molecular mechanisms, the development of new biomarkers of exposure and disease outcomes and studies focusing on intervention and prevention studies.

29 January 2019 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
Jerry HeindelJerry Heindel
Jerry Heindel
The Obesogen field developed from two separate scientific research areas, endocrine disruptors and the Developmental Origins of Health and Disease (DOHaD). Endocrine Disrupting Chemicals (EDCs) are exogenous chemicals or mixtures of chemicals that interfere with the action of hormones. Exposure to EDCs during early development (DOHaD) has been shown to increase susceptibility to a variety of diseases including infertility, asthma, breast and prostate cancer, early puberty, susceptibility to infections, heart disease, autoimmune disease, and attention deficit hyperactivity disorder/learning disability. The effects of EDCs on obesity and fat cell development first gained attention around the turn of the twenty-first century. In 2002 Dr. Paula Baillie-Hamilton wrote the first review article focusing on environmental chemicals and obesity. She suggested that the obesity epidemic correlated with the increased production of chemicals after World War II. Baillie-Hamilton identified studies showing that exposures to a variety of chemicals led to weight gain. Shortly after that a commentary on an article showing that nonylphenol would increase fat cell differentiation in vitro noted the Baillie-Hamilton article and made the point that perhaps obesity was due in part to exposure to EDCs. In 2006 the field of DOHaD/EDCs and obesity made a giant leap forward when Dr. Bruce Blumberg published a paper showing that tributyltin could lead to weight gain in mice and coined the term obesogen for a chemical that caused weight gain and lead to obesity. In 2011, the NIEHS developed the first funding initiative focused on obesogens. In the following years there have been several workshops focused on obesogens. This paper describes these early days that lead to the obesogen hypotheses and the growth of the field for a decade, leading to its prominence today, and provides some insight into where the field is moving.

1 December 2020 in Reproductive Toxicology
Verified
Journal Article
Closed access
Jerry HeindelJerry Heindel
Jerry Heindel
SBScott Belcher
Scott Belcher
JFJodi A. Flaws
Jodi A. Flaws
GPGail S. Prins
Gail S. Prins
SHShuk-Mei Ho
Shuk-Mei Ho
RZR. Thomas Zoeller
R. Thomas Zoeller